If you’ve ever handed a generic healthcare marketing agency your PRP or stem cell therapy service line and watched them apply the same playbook they use for urgent care clinics, you already know how that story ends: disapproved ads, thin content, and a lead pipeline full of people who were never going to book a $2,500 consultation in the first place.
Regenerative medicine marketing is a fundamentally different discipline — and the gap isn’t subtle. These treatments sit at the intersection of emerging science, high patient skepticism, and a regulatory environment that makes standard medical advertising look straightforward by comparison. Three core challenges separate this niche from everything else in healthcare marketing:
- Patient education burden: Most prospects have heard the words “stem cell therapy” or “PRP” but have no framework for what these treatments actually do, who they help, or why they cost what they do. Your marketing has to teach before it can convert.
- Regulatory complexity: FDA guidelines restrict specific outcome claims, and both Google and Meta have their own overlapping ad policies that flag regenerative treatment language faster than you’d expect.
- The trust gap: Years of “miracle cure” clinics and sensationalized headlines have made patients genuinely wary. They’re doing deep research before they ever contact your practice — and they’re looking for reasons to disqualify you.
Generic tactics skip straight to conversion without addressing any of these barriers. A specialized approach to regenerative medicine marketing doesn’t just help — it’s the only approach that actually works.
The demand side of this equation is hard to ignore. The global regenerative medicine market was valued at over $30 billion and is projected to keep climbing — driven by an aging population, rising rates of chronic musculoskeletal conditions, and a growing patient appetite for non-surgical alternatives to joint replacements and long-term medication.
That growth translates directly into search volume your practice can capture. Patients are actively typing queries like “alternatives to knee replacement surgery,” “non-surgical treatment for rotator cuff,” and “PRP therapy near me” into Google every day — often without a specific clinic in mind. They’re looking for a provider they can trust. The question is whether your practice shows up when they do.
The competitive landscape is expanding just as fast as patient demand. More clinics are adding PRP, stem cell, and exosome services to their offerings, which means the window for establishing local authority is narrowing. Practices that invest in visibility now — before their market becomes saturated — will be the ones capturing the majority of high-intent patient traffic over the next several years.
- Aging demographics: Adults 50+ are the core patient base for joint and orthopedic regenerative treatments — a population segment growing every year
- Cash-pay preference: Most regenerative treatments are out-of-pocket, meaning patients are motivated, self-selecting, and higher lifetime value
- Low local competition: Many markets still have few clinics with strong regenerative medicine marketing, creating real first-mover advantage
Here’s the uncomfortable reality every regenerative medicine clinic has to market against: your prospective patients have probably already encountered a “stem cell miracle” clinic online — research published in PNAS found 96% of clinic websites display misinformation. An estimated 2,750 U.S. clinics are offering unapproved stem cell injections, and the coverage of their inflated claims has left a significant portion of the patient population skeptical — even of legitimate, evidence-based providers. That skepticism isn’t a marketing obstacle you can outspend. You have to dismantle it directly.
The good news is that credibility is actually a competitive advantage in this space. Clinics that lead with transparency — explaining what treatments can and cannot do, citing peer-reviewed research, and setting realistic expectations upfront — stand out sharply against the noise of overpromised outcomes. Patients who’ve been burned by hype are actively looking for a provider who sounds honest rather than promotional.
Here are four concrete ways to build that credibility into your marketing materials:
- Use educational content to set realistic expectations — explain mechanisms, not miracles. “PRP uses your body’s own platelets to support the natural healing process” lands better than any superlative.
- Feature video testimonials from real patients — authentic stories from people describing their actual experience are harder to dismiss than written reviews.
- Link to published studies or professional associations when making treatment claims — sourcing signals scientific grounding, not salesmanship.
- Eliminate words like “cure” or “miracle” entirely — they trigger the exact skepticism you’re trying to overcome, and they put you on the wrong side of FDA and platform ad policies simultaneously.
Knowing your challenges and understanding the market opportunity are the starting line — not the finish. Effective regenerative medicine marketing requires a deliberate strategic framework built around three foundational decisions: who you’re targeting, what makes your practice worth choosing, and whether your website can actually close the deal once a patient lands on it.
Identify Your Ideal Regenerative Medicine Patient
Not every patient searching for regenerative treatments is the right fit for your practice. Your ideal patient profile typically looks like this: adults between 45 and 70, dealing with joint pain, orthopedic injuries, or chronic inflammation, who are motivated to avoid surgery and willing to pay out-of-pocket for the right solution. Understanding their demographics, search behavior, and decision triggers lets you focus your marketing budget on qualified leads — not curiosity clicks.
Craft a Unique Value Proposition Around PRP, Stem Cell, and Exosome Therapies
Why should a patient choose your clinic over the three others in your market offering the same treatments? Your unique value proposition should be specific — physician credentials, specialized protocols, proprietary equipment, or documented patient outcomes. Vague positioning like “compassionate care” won’t move a research-heavy patient. Clinical specificity will.
Build a High-Converting, HIPAA-Compliant Website
Your website is where strategy meets execution. It needs to load fast on mobile, carry dedicated service pages for each treatment, and feature prominent calls-to-action that make booking a consultation effortless. HIPAA-compliant forms aren’t optional — they’re the baseline. Every design decision should move a skeptical visitor one step closer to scheduling.
No single channel wins the patient acquisition game for regenerative medicine — and most clinics that struggle with marketing are trying to make one or two tactics carry the entire load. The practices consistently filling their consultation calendars use a coordinated mix that meets patients at every stage of their research journey.
- SEO and local SEO: Ranking for terms like “PRP therapy near me” or “stem cell treatment [city]” puts your practice in front of patients who are already looking. Optimizing your Google Business Profile — with treatment-specific services listed, weekly posts, and consistent patient reviews — is often the highest-leverage free move available to a regenerative clinic.
- Google Ads and paid social: Paid search and Facebook/Instagram ads can drive high-intent traffic quickly, but regenerative medicine ad policies require careful compliance. Educational angles and condition-based messaging tend to outperform direct treatment promotion — and keep your account from getting flagged.
- Educational content marketing and video: Blog posts, procedure explainers, and FAQ pages do double duty — they rank in search and actively counter the misinformation patients encounter before they ever contact you. Long-tail queries like “does PRP work for arthritis” drive serious research-phase traffic.
- Email and text nurture campaigns: Most regenerative medicine patients don’t book on their first site visit. Automated HIPAA-compliant drip sequences keep your practice top-of-mind and walk leads through the education they need to commit to a high-ticket consultation.
- Reputation management and patient testimonials: With 84% of patients checking reviews before choosing a provider, proactively generating Google reviews and responding to feedback isn’t optional — it’s infrastructure. Video testimonials extend that credibility further.
Most regenerative medicine marketing stops at getting the click. AI-driven systems go further — they analyze what happens after that click, using behavioral signals and appointment data to identify which prospects are genuinely ready to book a $3,000+ treatment and which ones need more education before they’ll commit.
Predictive analytics is the engine behind this shift. Instead of treating every form fill as an equal lead, AI tools process signals like page visits, content downloads, email open rates, and past appointment history to score leads by conversion likelihood. The practical result: you stop spending equal budget on everyone who expressed interest and start concentrating outreach on the patients most likely to show up for a consultation.
- AI chatbots and automated booking: A prospective PRP patient researching at 10 PM isn’t calling your front desk. An AI chatbot answers their questions in real time, qualifies their interest, and drops them directly into your scheduling system — capturing leads that would otherwise disappear overnight.
- Predictive targeting from behavior and appointment data: AI identifies patterns across your existing patient base — treatment type, visit frequency, referral source — and uses those patterns to prioritize which new leads deserve immediate follow-up versus longer nurture sequences.
- Personalized follow-up at scale: Automated sequences deliver condition-specific content, provider credentials, and financing information at the right moment in a prospect’s research journey — without your staff manually tracking every inquiry.
The net effect is a measurable reduction in cost per acquired patient, not just cost per lead.
If you spend any time around search marketing right now, you’ve probably noticed something shifting: patients are increasingly getting answers directly from AI without clicking a single link — 26% now choose providers via AI tools. Google’s AI Overviews now appear in over 82% of health-related searches, and tools like ChatGPT are reshaping how people research treatments like PRP and exosomes before they ever contact a clinic. That shift has direct implications for how you approach regenerative medicine marketing.
Generative Engine Optimization (GEO) is the practice of structuring your content so AI systems pull from it when generating answers. Think of it as the next evolution of SEO — but instead of optimizing for an algorithm ranking blue links, you’re optimizing for the machine summarizing results. If your clinic’s content isn’t formatted for AI consumption, you’re invisible in a search environment that’s moving fast in that direction.
The good news: GEO tactics are concrete and actionable right now. Here’s what actually moves the needle for regenerative medicine practices:
- Structured, scannable content: Clear headers, concise paragraphs, and direct answers to common patient questions — AI systems favor content that’s easy to parse and cite.
- Entity optimization: Consistently publish under your clinic name, link to your Google Business Profile, and earn mentions on authoritative medical sites to establish your practice as a recognized entity.
- Authoritative sourcing: Reference peer-reviewed research and FDA guidance — AI models weight content that cites trusted sources more heavily.
- FAQ-formatted content: Direct question-and-answer structure is among the most frequently surfaced by AI Overview results.
Clinics investing in GEO today are building visibility in a channel most competitors haven’t noticed yet.
The regulatory landscape for regenerative medicine advertising isn’t a minor footnote — it’s the terrain your entire marketing strategy has to navigate. The FDA restricts specific outcome claims about regenerative treatments, and both Google and Meta enforce their own overlapping policies on top of that. Getting this wrong doesn’t just mean a disapproved ad. It can mean a warning letter, a suspended account, or a landing page that quietly tanks your conversion rate because the compliance team flagged your copy.
The practical rule: what you say in your ads and on your website must reflect what the science actually supports — not what you wish it supported. That means avoiding terms like “cure,” “FDA-approved stem cell treatment,” and “guaranteed results,” which are either factually inaccurate or unsubstantiated under current regulatory standards.
Here’s a quick reference for the most common compliance missteps and how to correct them:
- “Stem cells cure arthritis” → “Stem cell therapy may support joint health and reduce inflammation”
- “Guaranteed results” → “Many patients report improved mobility following treatment”
- “FDA-approved stem cell treatment” → “Treatments performed by board-certified physicians in a licensed clinical setting”
Compliant copy doesn’t have to be weak copy. Mechanism-of-action language, physician credentials, and outcome-based patient language all build credibility without crossing regulatory lines. Working with a healthcare-specialized marketing partner who already knows where those lines are — rather than discovering them mid-campaign — is the most efficient path forward.
Not every agency that claims to do healthcare marketing is equipped to handle regenerative medicine specifically — and the difference matters more here than in almost any other medical niche. A generalist agency will learn your compliance constraints on your dime, discover mid-campaign that Google restricts stem cell ad language, and spend the first three months figuring out what a practice owner already knows.
The right partner brings regenerative medicine experience to the table before the first strategy call. When evaluating agencies, push past the pitch deck and ask direct questions. Vague answers about “brand awareness” and “digital presence” are red flags. Specific answers about cost-per-booked-patient benchmarks and FDA-compliant ad copy are green ones.
- Healthcare specialization: Do they understand HIPAA requirements, FDA advertising guidelines, and platform-specific policies for PRP and stem cell campaigns — or are they researching it as you talk?
- Regenerative medicine track record: Have they run campaigns specifically for PRP, stem cell, or exosome practices? Ask for concrete outcomes, not testimonials without numbers.
- Transparent performance reporting: Can you see exactly where your budget is going, what your cost per consultation is, and which channels are converting?
- AI and GEO capabilities: As AI search reshapes how patients find providers, is the agency actively building for that environment or still running a 2019 playbook?
The stakes in regenerative medicine marketing are too high for trial and error. A specialized partner who already understands the regulatory landscape and patient psychology of this niche will consistently outperform a generalist — starting from day one.
If you can’t measure it, you can’t improve it — and in a cash-pay specialty where a single patient can represent $3,000 to $10,000 in revenue, knowing exactly which marketing activities are generating that value isn’t optional. KPIs (key performance indicators) are the metrics that tell you whether your regenerative medicine marketing budget is working or quietly leaking.
Cost Per Lead and Cost Per Acquired Patient
Cost per lead (CPL) measures what you spend to generate one inquiry — a form fill, phone call, or chat. Cost per acquired patient goes one level deeper: what it actually costs to turn that inquiry into a booked, paying consultation. A low CPL means nothing if those leads never convert, so track both numbers together.
Lead to Consultation Conversion Rate
This is the percentage of leads who actually schedule and show up for a consultation. A consistently low rate signals a problem with your follow-up process, lead quality, or website experience — not necessarily your ad spend. It’s one of the most actionable metrics in your entire stack.
Return on Ad Spend and Lifetime Patient Value
ROAS (return on ad spend) is revenue generated divided by what you spent on ads. For high-ticket regenerative treatments, even a modest ROAS can represent strong profitability. Pair it with lifetime patient value — the total revenue a patient generates over their relationship with your practice, including repeat treatments and referrals — to understand what you can actually afford to spend acquiring each new patient.
- CPL benchmark: Varies by market and channel, but tracking trends over time matters more than hitting an arbitrary number
- Conversion rate warning sign: Below 20% lead-to-consultation typically indicates a follow-up or qualification problem
- LTV advantage: Patients who return for multiple treatment cycles dramatically improve your ROAS math
Everything covered in this article — the compliance framework, the channel mix, the AI tools, the KPI stack — is what we build and run for regenerative medicine practices every day at Target Patients MD. We’re not a generalist agency that added a healthcare vertical. This is the only niche we operate in, and regenerative medicine patient acquisition is what our platform was specifically engineered to handle.
Our proprietary A.L.I. 360 system — Attract, Learn, Influence — combines predictive analytics, Generative Engine Optimization, and HIPAA-compliant automation into one cohesive engine. It’s not a collection of disconnected tactics. It’s a single integrated platform that moves a prospective patient from their first Google search to a booked consultation without your front desk chasing every lead manually.
- Attract: GEO-optimized content, compliant paid campaigns, and regenerative medicine SEO designed to surface your practice in both traditional and AI-powered search results
- Learn: AI tools that analyze patient behavior and appointment data to sharpen targeting and reduce wasted spend over time
- Influence: Automated follow-up sequences, video testimonial strategies, and reputation systems that convert research-phase browsers into scheduled consultations
Practices using our platform have seen patient acquisition lifts of up to 377%. We’ve helped more than 735 practitioners grow their patient base with measurable, transparent outcomes — not vague promises about impressions and reach. Learn more about Target Patients MD and what a done-for-you patient acquisition system looks like for your specific practice.
Regenerative medicine marketing comes with a specific set of questions that practice owners ask repeatedly — often because the answers aren’t easy to find in one place. Here are direct, practical responses to the ones that come up most.
- How big is the regenerative medicine market? The global regenerative medicine market is valued at over $30 billion and remains one of the fastest-growing segments in healthcare. Patient demand for non-surgical alternatives continues to accelerate, creating significant opportunity for clinics that invest in visibility and education now.
- What is the biggest challenge in marketing regenerative medicine services? Overcoming patient skepticism fueled by exaggerated claims from unregulated providers. Clinics that prioritize education, transparency, and compliance consistently outperform those that lead with promotional messaging.
- What are the 4 P’s of healthcare marketing? Product, Price, Place, and Promotion — applied to regenerative medicine, this means defining your treatment offerings, setting transparent pricing, optimizing clinic accessibility, and communicating with patients through compliant, educational channels.
- How much should a regenerative medicine clinic budget for marketing? Most practices allocate between 5–15% of revenue, though the right number depends on growth goals, local competition, and current acquisition costs. Higher-ticket services like stem cell therapy often justify investment at the upper end of that range.
- Can regenerative medicine clinics run Google and Facebook ads for stem cell therapy? Yes, with restrictions. Both platforms limit claims about regenerative treatments. Ads must avoid unproven outcome language and comply with platform-specific healthcare policies to remain active.
The regenerative medicine industry isn’t a niche anymore — it’s a full-scale market, and the numbers reflect it. The global sector is valued at over $30 billion and is expanding rapidly across orthopedics, sports medicine, aesthetics, and integrative health — with adjacent service lines like peptide therapy following the same growth trajectory.
What’s driving this growth isn’t just physician enthusiasm. It’s patient demand. An aging population is actively seeking ways to stay active without surgery, and chronic musculoskeletal conditions — knee osteoarthritis, rotator cuff injuries, degenerative disc disease — are exactly the conditions regenerative treatments are designed to address, with 32.5 million Americans affected by osteoarthritis alone. These patients are motivated, self-directed, and willing to pay out-of-pocket for solutions that align with their goals.
For clinics, this creates a meaningful window — but it’s not unlimited. The market is attracting new entrants quickly, and local competition is intensifying in markets that were underserved just two or three years ago. The practices capturing patient volume right now share one thing in common: they made deliberate investments in regenerative medicine marketing before their markets became crowded.
- Growing patient base: Adults 50+ represent the core demographic for orthopedic regenerative treatments — a segment that grows every year
- High-value patient profile: Cash-pay patients are self-selecting, motivated, and tend to generate stronger lifetime value than insurance-dependent patient populations
- First-mover advantage: Many local markets still lack a dominant regenerative medicine brand — that position is available to the clinic that moves first
With your target patient defined, your value proposition sharpened, and your website built to convert, the next layer of a strong regenerative medicine marketing strategy is channel sequencing — deciding which tactics to activate first based on where you are in your practice growth cycle.
Early-stage practices typically benefit most from establishing local search authority before investing heavily in paid campaigns. Organic visibility compounds over time, while paid traffic stops the moment your budget does. A sequenced approach — local SEO and Google Business Profile first, paid search layered in once your conversion infrastructure is solid — prevents the common mistake of spending on traffic before your site can handle it.
Growth-stage practices face a different challenge: scaling volume without sacrificing lead quality. This is where channel diversification matters. Relying on a single source — say, Facebook ads alone — creates fragility. If Meta changes its policies on regenerative treatment language (and it has), your entire pipeline disappears overnight.
A resilient regenerative medicine marketing strategy distributes patient acquisition across multiple channels so no single policy change or algorithm update can crater your lead flow. Consider the role each channel plays:
- SEO and local search: Long-term visibility that builds authority and captures high-intent queries
- Paid campaigns: Fast-moving volume lever for specific treatment promotions or seasonal pushes
- Content and email: Mid-funnel education that moves research-phase prospects toward consultation
- Reputation systems: Conversion infrastructure that closes patients who are already comparison-shopping
The channel overview covered earlier in this article maps the full menu — SEO, paid search, content, email, and reputation. What’s worth going deeper on is how each channel behaves differently when you’re marketing regenerative treatments specifically, and where the execution details separate clinics that generate consistent patient volume from those spinning their wheels.
Local SEO deserves more attention than most practices give it. Your Google Business Profile isn’t a directory listing — it’s an active patient acquisition tool. Clinics that publish weekly treatment-specific posts, proactively populate the Q&A section with common patient questions, and upload clinical photos consistently outperform competitors with static profiles, often without spending a dollar on ads.
On the paid side, the compliance constraints covered earlier actually create a counterintuitive advantage: condition-based ad creative consistently outperforms treatment-based creative. Ads targeting “knee pain without surgery” or “non-surgical joint treatment” reach patients earlier in their decision process — before they’ve already chosen a competitor — and face fewer platform restrictions than ads leading with “stem cell therapy.”
Content marketing and video work best when mapped to the patient journey rather than treated as a general awareness play. A blog post answering “how long does PRP take to work” captures a patient in active consideration mode — someone already comparing options, not just browsing. That specificity is what drives qualified traffic rather than curiosity clicks.
- Email and SMS sequences: Segment by treatment interest so a prospect who asked about PRP receives PRP-specific content, not a generic newsletter
- Video testimonials: Short-form (60–90 seconds) for social, longer patient stories embedded on dedicated service pages where research-mode visitors spend the most time
The agency selection decision deserves its own attention beyond the general criteria already covered — specifically around what a productive partnership actually looks like once you’ve signed a contract. The onboarding process reveals more about an agency’s regenerative medicine marketing capabilities than any sales presentation will.
A qualified partner should arrive with pre-built compliance guardrails for your ad copy, not discover platform restrictions alongside you. They should have existing relationships with regenerative medicine content frameworks — treatment-specific landing page templates, FDA-aligned messaging libraries, and local SEO structures built around the search behavior patterns of orthopedic and joint-pain patients specifically.
Beyond the initial setup, ongoing collaboration matters as much as the launch. Regenerative medicine ad policies shift. Google updates its healthcare advertising guidelines. Meta adjusts what it will and won’t approve for clinical treatment language. An agency that isn’t monitoring these changes in real time will cost you downtime, disapproved campaigns, and lost patient volume — often without flagging the problem until you notice the drop yourself.
Practical questions worth asking before you commit:
- How quickly do they respond when an ad is disapproved or a campaign needs compliance revision?
- Do they have a dedicated point of contact who understands your treatment mix — not just an account manager rotating across industries?
- How do they handle platform policy changes that affect regenerative treatment advertising mid-campaign?
- What does their reporting cadence look like, and will you see cost-per-booked-patient data or just surface-level metrics?
Getting patients through the door is only half the equation. What happens after a patient inquires — or after their first treatment — determines whether your regenerative medicine marketing investment actually pays off long-term. Patient Relationship Management (PRM) systems are the infrastructure that handles this side of the equation, and most regenerative clinics underinvest in them significantly.
A PRM system centralizes every patient interaction: appointment history, treatment preferences, follow-up status, and communication logs. For regenerative medicine practices specifically, this matters more than in most specialties because the treatment journey rarely ends after one session. PRP series, follow-up injections, and repeat exosome protocols mean a single patient can represent multiple revenue cycles — if your practice has a system in place to manage that relationship proactively.
The practical benefits for a regenerative clinic include:
- Streamlined appointment management: Patients can view availability and self-schedule without calling the front desk, reducing friction for the research-heavy patient profile typical of this niche
- Automated recall and reactivation: Flag patients due for follow-up treatments and trigger outreach automatically, without relying on staff memory
- Feedback collection at scale: Post-visit surveys capture outcome data you can use for compliance-friendly testimonials and internal quality improvement
- Centralized communication history: Every text, email, and call logged in one place so no lead or existing patient falls through the cracks
The distinction worth drawing: a PRM system isn’t a replacement for the AI-driven lead nurturing covered earlier — it’s the layer that manages patients once they’ve converted, keeping them engaged and generating the repeat visits that drive lifetime patient value.
The KPIs covered earlier tell you whether your campaigns are working — but measurement doesn’t stop at the dashboard. The real discipline is building a feedback loop that continuously feeds performance data back into your strategy, so your regenerative medicine marketing gets sharper with every campaign cycle rather than plateauing after launch.
Start by establishing a baseline for each channel before you optimize anything. Without a starting point, you can’t distinguish a genuine improvement from normal fluctuation. Most practices skip this step and end up chasing noise instead of signal.
Once your baseline is set, focus your optimization effort on the highest-leverage variables first:
- Landing page conversion rate: Small copy or layout changes — moving a booking form above the fold, swapping a generic headline for a condition-specific one — routinely produce 20–30% lifts without touching your ad spend
- Ad creative rotation: Condition-based creative (knee pain, rotator cuff, joint inflammation) tends to outperform treatment-based creative over time — test both and let data confirm it for your specific market
- Follow-up sequence timing: If leads are going cold, the problem is often response lag, not lead quality — most high-intent patients expect contact within the first hour of inquiry
- Review generation cadence: Practices that systematically request reviews after positive outcomes see compounding local SEO gains that paid campaigns can’t replicate
Monthly performance reviews — not quarterly — are the minimum cadence for a cash-pay specialty where a single month of underperformance can represent significant lost revenue.
Effective regenerative medicine marketing doesn’t operate in isolation — it needs a technology layer that connects patient communication, scheduling, and follow-up into a single operational system. That’s where purpose-built practice management platforms close the gap between marketing activity and actual booked revenue.
The distinction here is important: the AI-driven lead nurturing and predictive analytics covered earlier focus on converting prospects into consultations. Practice management technology takes over once a patient enters your orbit — handling the operational side of the relationship so your marketing investment doesn’t leak at the finish line.
For regenerative medicine clinics specifically, integrated platforms deliver measurable advantages across the patient lifecycle:
- Unified communication tools: Phone, text, and online chat managed from a single interface so no inquiry goes unanswered — regardless of how a patient first contacts your practice
- Automated appointment reminders: Reduce no-show rates for high-ticket consultations through timely, personalized text and email confirmations
- Integrated payment processing: Streamline the cash-pay transaction experience that defines most regenerative treatment purchases
- Review generation at scale: Systematically prompt satisfied patients for Google reviews at the optimal post-visit moment, compounding your local SEO gains over time
The practices generating consistent patient volume treat their technology stack as a revenue system, not an administrative tool. When your marketing channels, communication platform, and scheduling infrastructure work together, the result is a patient experience that converts — and retains.
